Back to top
more

Integra LifeSciences (IART)

(Delayed Data from NSDQ)

$16.62 USD

16.62
558,368

-0.30 (-1.77%)

Updated Sep 1, 2026 04:00 PM ET

After-Market: $16.61 -0.01 (-0.06%) 5:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (96 out of 248)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Integra LifeSciences (IART) Q3 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Integra (IART) delivered earnings and revenue surprises of -2.56% and 1.35%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

IART vs. IDXX: Which Stock Is the Better Value Option?

by Zacks Equity Research

IART vs. IDXX: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why Investors Should Retain Integra (IART) Stock Now

by Zacks Equity Research

International expansion and the strong prospects of the CSS segment bode well for Integra (IART).

Zacks Equity Research

Here's Why You Should Retain Integra (IART) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Integra (IART) based on the prospects of its CSS segment and a stable liquidity position.

Zacks Equity Research

Why Is Integra (IART) Down 7.9% Since Last Earnings Report?

by Zacks Equity Research

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth

by Zacks Equity Research

In spite of facing foreign exchange fluctuations across its non-U.S. business, Integra (IART) is successfully broadening its international footprint.

Zacks Equity Research

Integra's (IART) Q2 Earnings Top Estimates, 2023 View Cut

by Zacks Equity Research

In CSS, Integra (IART) registers strong growth owing to high single-digit growth in Advanced Energy and mid-single-digit growth in CSF management during Q2.

Zacks Equity Research

Integra (IART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Integra (IART) delivered earnings and revenue surprises of 24.56% and 1.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Device Stocks' Q2 Earnings on Jul 27: BSX, LH & IART

by Urmimala Biswas

Medical Device companies' second-quarter results are likely to reflect a year-over-year decline. Let's see how BSX, LH and IART fare this time.